Timothy Morris, DO
Interventional Cardiology · Sewell, NJNPI 1942292578
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 474 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,608 and has fallen 57.1% since, to $1,546 in 2025.
Across 474 payments — averaging $26.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$1K
- Abiomed$1K
- Abbott$1K
- AstraZeneca$1K
- Shockwave Medical, Inc$944
- Boston Scientific$890
- plus $6K from 30 others
Across 1 payment — averaging $5765.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tryton Medical, Inc.$6K
What the payments were for
- Travel & lodging$2982%
- Food & beverage$12,03398%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 18 | $1,458 |
| Abiomed | 31 | $1,136 |
| Abbott | 115 | $1,025 |
| AstraZeneca | 38 | $1,009 |
| Shockwave Medical, Inc | 19 | $944 |
| Boston Scientific | 42 | $890 |
| Inari Medical, Inc. | 5 | $795 |
| E.r. Squibb & Sons, L.L.C. | 24 | $663 |
| Medtronic(2 entities) | 9 | $531 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $495 |
| Novartis | 21 | $322 |
| Pfizer | 15 | $305 |
| Getinge USA Sales, LLC | 7 | $301 |
| Johnson & Johnson | 19 | $289 |
| Boehringer Ingelheim | 18 | $276 |
| Avinger Inc. | 4 | $241 |
| Amgen | 14 | $227 |
| Edwards Lifesciences | 6 | $184 |
| Livanova USA, Inc. | 1 | $182 |
| Cardiovascular Systems Inc. | 9 | $179 |
| Novo Nordisk | 12 | $174 |
| W. L. Gore & Associates, Inc. | 6 | $114 |
| Stryker | 1 | $104 |
| Irhythm Technologies, Inc. | 1 | $103 |
| Merck | 5 | $75 |
| Scpharmaceuticals Inc. | 3 | $55 |
| Amarin Pharma, Inc. | 3 | $44 |
| Akcea Therapeutics, Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| Tactile Systems Technology Inc | 1 | $27 |
| Medicomp Inc | 1 | $24 |
| Preventice Services, LLC | 1 | $23 |
| Lexicon Pharmaceuticals, Inc. | 1 | $23 |
| Cardinal Health 200 LLC | 1 | $21 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$1,248
- FLOWTRIEVER CATHETER, S$1,083
- Impella$538
- CT THROMBECTOMY SYSTEM KIT$379
- FARXIGA$364
- CAMZYOS$326
- AVVIGO Guidance System$268
- Protek Duo$182
- Resolute$174
- SYMPLICITY G3$159
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$151
- ELUVIA$114
- ELIQUIS$111
- Vascular Lithotripsy$110
- PANTHERIS$105
- ARTIX MT$104
- IN.PACT Admiral$104
- ZIO Patch$103
How this compares
$12,337 in reported general payments places this provider in the 60th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 184 | $210,135 |
| XareltoRivaroxaban | 48 | $55,292 |
| EntrestoSacubitril/Valsartan | 39 | $50,542 |
| BrilintaTicagrelor | 20 | $16,489 |
| FarxigaDapagliflozin Propanediol | 12 | $10,324 |
| Metoprolol Succinate | 398 | $6,244 |
| Atorvastatin Calcium | 306 | $4,105 |
| ClopidogrelClopidogrel Bisulfate | 289 | $4,097 |
| Carvedilol | 243 | $3,083 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 131 | $2,261 |
| Rosuvastatin Calcium | 172 | $2,026 |
| Ezetimibe | 56 | $1,973 |
| Losartan Potassium | 154 | $1,687 |
| Amlodipine Besylate | 183 | $1,575 |
| Torsemide | 51 | $1,418 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $305 | $210,135184 claims |
| Johnson & JohnsonXarelto | $289 | $55,29248 claims |
| NovartisEntresto | $322 | $50,54239 claims |
| AstraZenecaBrilinta, Farxiga | $1,009 | $26,81332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 166 interventional cardiology providers in New Jersey.
Other interventional cardiology in Sewell
- Ankitkumar PatelGlen Ridge$408K
- Ziad AbbudOcean$360K
- Ramin HastingsHasbrouck Heights$295K
- Michael LimHackensack$215K
- Darshan GodkarCedar Knolls$194K
- Ryan KapleHackensack$178K
- Matthew SayboltEatontown$175K
- Daniel KissEatontown$172K
- Kintur SanghviBordentown$139K
- Dimitrios KarmpaliotisMorristown$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.